
The Dawn of Precision Medicine: A Revolutionary Liquid Biopsy for Prostate Cancer
The innovative liquid biopsy platform may transform prostate cancer treatment by offering a noninvasive alternative to PSMA PET scans. This epigenetic test extracts comprehensive genomic information from a blood sample, providing a detailed tumor profile for personalized treatment. Led by Dr. Jacob